- Filed
- Nov 9, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Oct 15, 2021 | 1.12B sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 1.1B sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 1.09B sh |
| Shares Diluted restated | Q3 2021 · Sep 30, 2020 | 1.08B sh |
| Shares Diluted restated | Q3 2021 · Sep 30, 2020 | 995.6M sh |
| Capex | Q3 2021 · Sep 30, 2021 | $6.8M |
| Capex restated | Q3 2021 · Sep 30, 2020 | $16.1M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2021 | $95.9M |
| Operating Cash Flow restated | Q3 2021 · Sep 30, 2020 | $223.3M |
| Long Term Debt | Q3 2021 · Sep 30, 2021 | $1.33B |
| Long Term Debt | Q3 2021 · Dec 31, 2020 | $1.29B |
| Short Term Investments | Q3 2021 · Sep 30, 2021 | $252.6M |
| Short Term Investments | Q3 2021 · Dec 31, 2020 | $208.4M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $1.09B |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $1.36B |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | $3.01B |
| Stockholders Equity | Q3 2021 · Jun 30, 2021 | $3.02B |
| Stockholders Equity | Q3 2021 · Mar 31, 2021 | $2.94B |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | $2.94B |
| Stockholders Equity restated | Q3 2021 · Sep 30, 2020 | $2.81B |
| Stockholders Equity restated | Q3 2021 · Jun 30, 2020 | $1.74B |
| Stockholders Equity restated | Q3 2021 · Mar 31, 2020 | $1.86B |
| Stockholders Equity restated | Q3 2021 · Dec 31, 2019 | $1.98B |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $1.42B |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $1.33B |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $3.06B |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $3.27B |
| Current Assets | Q3 2021 · Sep 30, 2021 | $1.78B |
| Current Assets | Q3 2021 · Dec 31, 2020 | $1.86B |
| Total Assets | Q3 2021 · Sep 30, 2021 | $6.07B |
| Total Assets | Q3 2021 · Dec 31, 2020 | $6.21B |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | −$0.04 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | −$0.03 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.11 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.38 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | −$0.04 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | −$0.03 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.11 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.38 |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $49.2M |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $122.8M |
| Sga Expense restated | Q3 2021 · Sep 30, 2020 | $36.1M |
| Sga Expense restated | Q3 2021 · Sep 30, 2020 | $103.5M |
| Rd Expense | Q3 2021 · Sep 30, 2021 | $143.5M |
| Rd Expense | Q3 2021 · Sep 30, 2021 | $394M |
| Rd Expense restated | Q3 2021 · Sep 30, 2020 | $165.9M |
| Rd Expense restated | Q3 2021 · Sep 30, 2020 | $591.7M |
| Net Income | Q3 2021 · Sep 30, 2021 | −$41.7M |
| Net Income | Q3 2021 · Sep 30, 2021 | −$36.9M |
| Net Income | Q3 2021 · Jun 30, 2021 | $27.8M |
| Net Income | Q3 2021 · Mar 31, 2021 | −$23M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | −$122.2M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | −$376.4M |
| Net Income | Q3 2021 · Jun 30, 2020 | −$150.3M |
| Net Income restated | Q3 2021 · Mar 31, 2020 | −$103.9M |
| Operating Income | Q3 2021 · Sep 30, 2021 | −$12.3M |
| Operating Income | Q3 2021 · Sep 30, 2021 | $57M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | −$121.6M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | −$342.6M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $240.8M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $754.8M |
| Cost Of Revenue restated | Q3 2021 · Sep 30, 2020 | $235.9M |
| Cost Of Revenue restated | Q3 2021 · Sep 30, 2020 | $561.4M |
| Revenue | Q3 2021 · Sep 30, 2021 | $704.7M |
| Revenue | Q3 2021 · Sep 30, 2021 | $2.11B |
| Revenue restated | Q3 2021 · Sep 30, 2020 | $503.3M |
| Revenue restated | Q3 2021 · Sep 30, 2020 | $1.36B |